| Status | Study |
| Not yet recruiting |
Study Name: A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s) Condition: Arthritis, Psoriatic Date: 2017-05-19 Interventions: Drug: Guselkumab Participants |
| Not yet recruiting |
Study Name: Chronic Inflammatory Disease, Lifestyle and Treatment Response Condition: Autoimmune Diseases Inflammatory Bowel Diseases Crohn Dise Date: 2017-05-17 Interventions: Other: Primary exposure variable |
| Not yet recruiting |
Study Name: A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Condition: Arthritis, Psoriatic Date: 2017-05-16 Interventions: Drug: Guselkumab Participants |
| Not yet recruiting |
Study Name: Pharmacist CVD Intervention for Patients With Inflammatory Arthritis Condition: Inflammatory Arthritis Cardiovascular Risk Factor Rheumato Date: 2017-05-11 Interventions: Other: CV risk assessment and modification of global risk Individualized CV risk assessment using the va |
| Not yet recruiting |
Study Name: A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis Condition: Psoriatic Arthritis Date: 2017-05-04 Interventions: Drug: Ixekizumab Administered |
| Completed |
Study Name: The DIET Trial - Dietetic Intervention in Psoriatic Arthritis Condition: Arthritis, Psoriatic Metabolic Syndrome Date: 2017-04-06 Interventions: Dietary Supplement: Diet + supplementation |
| Enrolling by invitation |
Study Name: A Study Comparing ABT-494 to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug Condition: Psoriatic Arthritis Date: 2017-04-04 Interventions: Drug: ABT-494 Oral tablet |
| Enrolling by invitation |
Study Name: A Study Comparing ABT-494 to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug Condition: Psoriatic Arthritis Date: 2017-04-04 Interventions: Drug: ABT-494 Oral tablet |
| Recruiting |
Study Name: Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsA Condition: Psoriatic Arthritis Date: 2017-04-04 Interventions: Drug: Methotrexate subjects wi |
| Recruiting |
Study Name: A Study to Assess Efficacy and Safety of Filgotinib in Active Psoriatic Arthritis Condition: Psoriatic Arthritis Date: 2017-03-30 Interventions: Drug: filgotinib one filgotini |